Highbridge Capital Management’s ICU Medical ICUI Stock Holding History

Highbridge Capital Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,856	Closed	-$468K	–	1118
2018 Q1	$468K	Buy	+1,856	New	+$436K	0.01%	724
2016 Q3	–	Sell	-16,618	Closed	-$1.87M	–	1473
2016 Q2	$1.87M	Buy	+16,618	New	+$1.72M	0.03%	445
2016 Q1	–	Sell	-4,138	Closed	-$467K	–	1625
2015 Q4	$467K	Buy	+4,138	New	+$457K	0.01%	1020
2015 Q3	–	Sell	-36,275	Closed	-$3.47M	–	1677
2015 Q2	$3.47M	Buy	+36,275	New	+$3.39M	0.04%	380
2015 Q1	–	Sell	-10,394	Closed	-$851K	–	1481
2014 Q4	$851K	Buy	10,394 +260	+3%	+$19.9K	0.01%	691
2014 Q3	$650K	Buy	+10,134	New	+$621K	0.01%	789
2014 Q1	–	Sell	-45,934	Closed	-$2.93M	–	1142
2013 Q4	$2.93M	Sell	45,934 -64,000	-58%	-$4.12M	0.04%	341
2013 Q3	$7.47M	Buy	109,934 +105,435	+2,344%	+$7.53M	0.08%	270
2013 Q2	$324K	Buy	+4,499	New	+$298K	﹤0.01%	1015

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Highbridge Capital Management's ICUI Position: Q2 2018 in Review

Highbridge Capital Management sold out of ICU Medical (ICUI) in Q2 2018, closing a stake of 1,856 shares — an estimated $468K sold.

Highbridge Capital Management first reported a position in ICUI in Q2 2013 and held it in 9 quarters. The position peaked at $7.47M in Q3 2013. 344 funds tracked by Wall St. Rank hold ICUI as of Q2 2018.

Highbridge Capital Management reported no remaining ICU Medical position as of Q2 2018 after selling out during the quarter.
Highbridge Capital Management sold 1,856 ICU Medical shares in Q2 2018, an estimated $468K.
Highbridge Capital Management first reported a position in ICU Medical in Q2 2013 and held it in 9 quarters.
Highbridge Capital Management's ICU Medical position peaked at $7.47M in Q3 2013.
344 funds tracked by Wall St. Rank held ICU Medical as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.